Eden Research (EDENE)

Currency in GBP
2.90
+0.05(+1.75%)
Closed·
Advertisement

Eden Research (EDENE) Price Discussion

Eden is like a woman who looks beautiful when she wears make-up... but in the morning (in a few years' time) the truth ‘ll be discovered.
More news from China, the world's largest market for table grapes: 3EA will never be registered. Eden is beautiful, with beautiful displays. But if you know it... it's just costs on top of costs on top of costs on top of expenses.
The third truth is that Corteva-treated seed has not caught on. They want to increase the costs of the only three active ingredients that I produce, 3EA. Meanwhile, generic prices are falling (fludioxonil+cyprodinil). They have very high management costs: patents, admission requests, manager salaries (like BASF or Bayer).
Two great truths. Cedroz and the partnership with Certis are not profitable. Mevalone is too expensive. And the raw material costs too much. The Acaricide project cannot take off, as its effectiveness is too low (60% open field). The partnership with Syngenta on the ornamental side is worth 0.01% of the market. It's smoke and mirrors...
Advertisement
What a great speculation! They had been waiting for a rise for some time. It's a pity that Mevalone, at the current market price, would cost seven times as much as treatments for fungi, excluding Botrytis! 8,000 hectares treated. 1%. Based on realistic analyses. €90 per hectare per treatment, compared to €14 for copper. No one spends that much. Not even on champagne.
It looks like Eden is a slow burner. Definitely one for the long-term. Now at 6.95 an excellent buy. Directors have been chosen wisely and yesterdays announcement by EU that it was aiming to halve the use of pesticides and promote organic farming by 2030. Eden recently got certified for use on organic crops. Great company that is part of the new wave for this century.
The corteva deal should increase edens wealth.?
No NASTY chemicals here. Perfectly set up for a bright long term future.
Advertisement
Research scientists at helm gene splice understanding natural suspensions of terpenes leading in fighting diseases and controlling pest infestation in plants now with many patents throughout world
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.